(Q54086129)
Statements
Phase I trial of the chimeric anti-GD2 monoclonal antibody ch14.18 in patients with malignant melanoma (English)
Saleh MN
Khazaeli MB
Wheeler RH
Allen L
Tilden AB
Grizzle W
Reisfeld RA
Gillies SD
1 January 1992